Innovation Credit (Innovatiekrediet): a loan repaid only if the project succeeds

Order emails retyped every morning, a forecast that misses, a planning in one person's head: that rarely calls for a government loan. The Innovation Credit is for something else, a technical development project with high costs and a real chance of failing. It is a loan from RVO, not a subsidy, and it is repaid only if the project succeeds. The headline of €10 million says little for a company of 20-250 people. What matters is that it covers 25-45% of project costs, and that at least 55% comes from elsewhere.Updated: November 2026

Of project costs, without collaboration
25-45%
At least, from other sources
55%
Budget 2026
€50M
All of 2026, first-come, first-served
Open
  • Wholesaler: nobody retypes two of three order emails any more (3,300 of 5,017, measured September 2026)
  • Masparts predicts quotes with 84% accuracy
  • Forecast for new products: from 40% to 86% accuracy, at a market leader in construction tools, measured on its own history
1Quick answer
  1. Retyping orders or a forecast that misses rarely calls for a government loan. The Innovation Credit is for a technical development project with high costs and a real chance of failing.

  2. It is a loan, not a subsidy, and is repaid only if the project succeeds, technically or commercially.

  3. Without collaboration it covers up to 45% (small company), 35% (medium-sized) or 25% (large) of project costs; with collaboration up to 50% for SMEs. At least 55% comes from other sources. Budget 2026: €50 million, maximum €10 million for a technical project.

  4. Open for applications all of 2026, first-come, first-served. Nothing is known yet about 2027 (source: RVO).

  5. For 20-250 people only realistic with a real technical development project and high costs. First step: a 30-minute intro call. If it does not fit, we say so.

2Status & timing

When can you apply?

For most schemes the opening date is what counts, the budget is often gone on day one. Here's the live status.

Innovatiekrediet

Year-round
Apply
Year-round
Allocation
rolling (year-round)
Start prep
~12 weeks ahead
Max
€10 mln (technisch) / €5 mln (klinisch)
Budget
€50 miljoen (waarvan €10 mln klinisch, €10 mln technisch, tot €30 mln gecombineerd)

You can apply year-round, but budget is allocated in order of arrival. Apply early in the year while budget lasts.

Check whether you qualify

Leave your region and email. We'll reach out personally to check whether you qualify for Innovatiekrediet and to prepare the application with you.

For: Innovatiekrediet

We don't blast newsletters, we contact you personally, well before the opening date, to prepare your application.

We design the project and help write the application

Stratalytic is a team of solution architects, data scientists and engineers. We design and build the project and help write the application, so it describes work that actually happens. The first step is an intro call of 30 minutes, no obligation.

3The scheme5 topics
01

A loan, not a subsidy

The Innovation Credit (Innovatiekrediet) is a loan from RVO for a technical or clinical development project. According to RVO it is repaid only if the project succeeds, technically or commercially. That is the difference from a bank loan.

The headline of €10 million says little for a company of 20-250 people. It is the ceiling for a technical project, and the total budget for 2026 is €50 million. What matters at this size is the share of the costs the credit covers, and what has to come from elsewhere.

02

What it covers, and what you pay yourself

Without collaboration the credit covers up to 45% of the project costs for a small company, 35% for a medium-sized company and 25% for a large company. With collaboration it is up to 50% for SMEs (40% for a large company). At least 55% comes from other sources: own resources, investors or other schemes. RVO names no minimum for the project costs on the scheme page.

The WBSO can run alongside for the labour costs of development work, and the MIT scheme for a feasibility study or collaboration, but not for the same costs twice. We check that per project.

03

Does it fit a company of 20-250 people?

It fits a technical development project with high costs: a new product, a new process, something that does not exist yet and whose outcome is uncertain, with a plan to bring it to market. The company must be able to carry the 55% or more that the credit does not cover.

It does not fit the daily work problems we hear most: order emails that are retyped, a forecast that misses, stock levels nobody trusts, a planning that lives in one head. That is work with technology that already exists. For a wholesaler or production company the WBSO is usually the better route, for the technical part, or a small first step without subsidy. For software and AI projects the same question applies: is the solution new, or only new to this company?

04

Technical vs. clinical track

The technical track is for all non-medical development projects: software, hardware, process technology and materials, up to €10 million. The clinical track is for medical innovations that need clinical trials, up to €5 million, with extra requirements on patient safety and registration. For a production or wholesale company, the technical track almost always applies.

05

Applying, and where things stand

The Innovation Credit is open for applications all of 2026 (1 January to 31 December), first-come, first-served until the annual budget is used up. Nothing is known yet about 2027 (source: RVO).

An application needs a technical project plan with the technical risks, a business case with market analysis, a financing plan for the remaining costs, a project budget and recent annual accounts. We assess first whether the project is technically new enough. If it is not, we say so, and no proposal follows.

4Process

How does it work?

  1. A 30-minute intro call

    We go through the project idea and the work problem behind it, and say whether the Innovation Credit, the WBSO or a small first step fits.

  2. Is it technically new enough?

    We assess the technical risk and the costs. If the work uses technology that already exists, we say so, and no proposal follows.

  3. Application, then build

    If the project fits, we write the technical project plan and the application. We build next to the existing systems, and the team keeps control.

5FAQ

Frequently asked questions

What exactly is the Innovation Credit?

The Innovation Credit (Innovatiekrediet) is a loan from RVO for a technical or clinical development project, not a subsidy. According to RVO the credit is repaid only if the project succeeds, technically or commercially. The exact conditions are in the decision issued when the credit is awarded.

Does the Innovation Credit fit a company of 20-250 people?

Only with a real technical development project and high costs: something that does not exist yet, with an uncertain outcome and high project costs. At least 55% of the costs come from other sources, so the company must be able to carry that itself. For processing order emails automatically, improving a forecast or getting stock in order it is usually not meant: that is work with existing technology. The WBSO fits better there, or a small first step without subsidy.

How much financing can I get?

Without collaboration the credit covers up to 45% of project costs for a small company, 35% for a medium-sized company and 25% for a large company. With collaboration it is up to 50% for SMEs (40% for a large company). At least 55% comes from other sources. The maximum is €10 million for a technical project and €5 million for a clinical project; the budget for 2026 is €50 million.

What is the difference between a loan and a grant?

A grant like the WBSO does not have to be repaid. The Innovation Credit is a loan: the amount comes in upfront. The difference from a bank loan is that repayment depends on the success of the project. The project must still be able to start on its own strength, because at least 55% comes from other sources.

What happens if the project does not succeed?

According to RVO the credit is repaid only if the project succeeds, technically or commercially. RVO assesses case by case whether the project was carried out according to plan and whether the money was spent properly. That is in the decision, which we go through with the company beforehand.

What is the difference between the technical and clinical track?

The technical track covers all development projects outside the medical sector, such as software, hardware, process technology or materials, with a maximum of €10 million. The clinical track is for medical innovations with clinical trials, up to €5 million. For a production or wholesale company the technical track almost always applies.

Can I combine the Innovation Credit with the WBSO or MIT?

Often, yes. The WBSO reduces payroll tax on hours spent on technical development work; the MIT can cover a feasibility study or a collaboration project. State aid rules apply to the same costs, so we check per project what can be combined.

Is the Innovation Credit open now?

Yes. It is open for applications all of 2026 (1 January to 31 December), first-come, first-served until the annual budget is used up. Nothing is known yet about 2027 (source: RVO).

Which documents are needed for the application?

A technical project plan with the technical risks, a business case with market analysis, a financing plan for the remaining costs, a project budget with cost breakdown, and recent annual accounts. We first assess whether the project is technically new enough, before anyone starts on those documents.

6Sources & official references

Verified information from authoritative sources

Thirty minutes to see where the biggest impact is.

An honest estimate in numbers, even if the answer is that it does not pay off.